'Marketing approval' diaporamas de présentation

HOW TO CONDUCT AN INSPECTION

HOW TO CONDUCT AN INSPECTION. CONTENTS. Objectives Scope Qualifications of an Inspector Qualities Communication Skills Inspection Process Types of Inspection Report Writing. OBJECTIVES. To promote harmonization. To assist government inspectors in assessing GMP compliance for cosmetics.

1.04k views • 52 slides

Human Subject Prot ections:

Human Subject Prot ections:. Carleton College October 10, 2002 Tom Puglisi, PhD. Compliance Issues. The Protection of Human Subjects in Research: Compliance Issues. Pharmaceutical and Regulatory Congress and Best Practices Forum November 14, 2002 Tom Puglisi, PhD.

552 views • 43 slides

Patent Term Extension to drugs and new regenerative medical products in Japan

Patent Term Extension to drugs and new regenerative medical products in Japan. February 2015, INDIA Kiyoshi Kuzuwa Patent Attorney. Table of contents. Patent Term Extension (max. 5 yrs.) for pharmaceutical/agrochemical products

414 views • 41 slides

WHO Prequalification of Medical Products (medicines, vaccines, diagnostics and medical devices)

448 views • 24 slides

Towards equitable and affordable medicine prices policy in Jordan

315 views • 23 slides

Organized by WIPO in Cooperation with GCC Patent Office Saudi Arabia, Riyadh 15-16 October, 2012

Sub-regional Workshop on the Protection of Invention in Pharmaceutical Sector, Patent, Undisclosed Information and Health Policies. Organized by WIPO in Cooperation with GCC Patent Office Saudi Arabia, Riyadh 15-16 October, 2012.

325 views • 22 slides

294 views • 15 slides

Consultative expert working group - proposals

Consultative expert working group - proposals. Barcelona 04.10.2011. Four proposals for innovative financing. A new indirect tax Voluntary contributions from businesses and consumers Taxation of repatriated pharmaceutical industry profits New donor funds for health research and development.

239 views • 14 slides

Data Exclusivity in Free Trade Agreements and Access to Originator (R&D Pharma) Medicine

143 views • 14 slides

ICORD 2009: Inching towards Integration--- the NIH and FDA seek IOM Input on a National Rare Disease Policy

ICORD 2009: Inching towards Integration--- the NIH and FDA seek IOM Input on a National Rare Disease Policy. Timothy Cote, MD MPH Director, Office of Orphan Products Development, Food and Drug Administration, Rockville, MD, USA Monday, Feb 23, 2009. Research Impulse Creative Peer-governance

223 views • 6 slides

Probability of Success for Investigational Drugs Is Small

Probability of Success for Investigational Drugs Is Small. Approximately 20% of self-originated new drugs that enter clinical testing will receive U.S. marketing approval. 1. Clinical Approval Success Rates by Therapeutic Class 1.

355 views • 1 slides